Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Company”) today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business ...

Plus, Friends of the CFDA names new chair.

Mid-market investor Bridgepoint has agreed to buy Waldencast's Obagi Medical dermatological skincare and aesthetics business in a deal with an enterprise value of up to $460 million.

In recent months, the UK market has faced challenges as the FTSE 100 index experienced declines due to weak trade data from China, impacting companies closely tied to its economic performance. Amid ...

Bridgepoint Group Plc is set to raise about €5 billion ($5.8 billion) to target financing opportunities in Europe’s direct lending market, people with knowledge of the matter said.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Add Yahoo as a preferred source to see more of our stories on Google. PARIS — Bridgepoint is set to acquire RoC Skincare, the French dermatological brand launched in 1957. The undisclosed investment ...

‘The market has come towards the sellers, but the sellers have also now agreed to reduce their expectations,’ the Bridgepoint chief investment officer told PE Hub in this NEXUS 2025 preview interview.

The Consumer Financial Protection Bureau (CFBP) took action on Monday against Ashford University and the University of the Rockies, two for-profit colleges operated by Bridgepoint Education Inc (NYSE: ...